tetano
Editor, Senior Moderator
J Neurosurg Anesthesiol. 2020 Apr 15. doi: 10.1097/ANA.0000000000000691. [Epub ahead of print]
Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations from Society for Neuroscience in Anesthesiology & Critical Care (SNACC).
Flexman AM[SUP]1[/SUP], Abcejo A[SUP]2[/SUP], Avitisian R[SUP]3[/SUP], De Sloovere V[SUP]4[/SUP], Highton D[SUP]5[/SUP], Juul N[SUP]6[/SUP], Li S[SUP]7[/SUP], Meng L[SUP]8[/SUP], Paisansathan C[SUP]9[/SUP], Rath GP[SUP]10[/SUP], Rozet I[SUP]11[/SUP].
Author information
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has several implications relevant to neuroanesthesiologists, including neurologic manifestations of the disease, impact of anesthesia provision for specific neurosurgical procedures and electroconvulsive therapy, and healthcare provider wellness. The Society for Neuroscience in Anesthesiology and Critical Care appointed a task force to provide timely, consensus-based expert guidance for neuroanesthesiologists during the COVID-19 pandemic. The aim of this document is to provide a focused overview of COVID-19 disease relevant to neuroanesthesia practice. This consensus statement provides information on the neurological manifestations of COVID-19, advice for neuroanesthesia clinical practice during emergent neurosurgery, interventional radiology (excluding endovascular treatment of acute ischemic stroke), transnasal neurosurgery, awake craniotomy and electroconvulsive therapy, as well as information about healthcare provider wellness. Institutions and healthcare providers are encouraged to adapt these recommendations to best suit local needs, considering existing practice standards and resource availability to ensure safety of patients and providers.
PMID:32301764DOI:10.1097/ANA.0000000000000691
Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations from Society for Neuroscience in Anesthesiology & Critical Care (SNACC).
Flexman AM[SUP]1[/SUP], Abcejo A[SUP]2[/SUP], Avitisian R[SUP]3[/SUP], De Sloovere V[SUP]4[/SUP], Highton D[SUP]5[/SUP], Juul N[SUP]6[/SUP], Li S[SUP]7[/SUP], Meng L[SUP]8[/SUP], Paisansathan C[SUP]9[/SUP], Rath GP[SUP]10[/SUP], Rozet I[SUP]11[/SUP].
Author information
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has several implications relevant to neuroanesthesiologists, including neurologic manifestations of the disease, impact of anesthesia provision for specific neurosurgical procedures and electroconvulsive therapy, and healthcare provider wellness. The Society for Neuroscience in Anesthesiology and Critical Care appointed a task force to provide timely, consensus-based expert guidance for neuroanesthesiologists during the COVID-19 pandemic. The aim of this document is to provide a focused overview of COVID-19 disease relevant to neuroanesthesia practice. This consensus statement provides information on the neurological manifestations of COVID-19, advice for neuroanesthesia clinical practice during emergent neurosurgery, interventional radiology (excluding endovascular treatment of acute ischemic stroke), transnasal neurosurgery, awake craniotomy and electroconvulsive therapy, as well as information about healthcare provider wellness. Institutions and healthcare providers are encouraged to adapt these recommendations to best suit local needs, considering existing practice standards and resource availability to ensure safety of patients and providers.
PMID:32301764DOI:10.1097/ANA.0000000000000691